Award

Klinman touted for ‘willingness to set aside old theories'

She won the ASBMB's 2015 Mildred Cohn Award in Biological Sciences
Elizabeth Meier
By Elizabeth Meier
March 1, 2015

Judith Klinman of the University of California, Berkeley, won the American Society for Biochemistry and Molecular Biology’s Mildred Cohn Award in Biological Chemistry for her far-reaching contributions to the field of mechanistic enzymology.

The Cohn award honors the scientific accomplishments and character of the late Cohn, the first president of the ASBMB. The award recognizes scientists who have advanced significantly the understanding of biological chemistry using innovative physical approaches.

klinman-web.jpg "I am deeply honored to be this year’s recipient of the Mildred Cohn Award. Mildred prevailed in the absence of opportunities for women in science, was a model for how women can successfully combine family with career, worked alongside many of the giants in biochemistry and pioneered the use of NMR to understand enzyme mechanism. She was a remarkable scientist and mentor whose deep understanding of science and the world were an inspiration to me and all who were privileged to know her. " — JUDITH KLINMAN

“Judith Klinman’s accomplishments truly parallel those of Mildred Cohn, with respect to outstanding scientific achievement and advancing the cause of women in science,” affirmed Natalie G. Ahn of the University of Colorado Boulder, who nominated Klinman for the award. “As the first woman professor in any of the physical sciences at UC Berkeley, the first tenured female professor in the UC Berkeley chemistry department and later as the first woman chair of the chemistry department, she has been instrumental in changing attitudes toward women in science.”

Klinman earned her Ph.D. in organic chemistry from the University of Pennsylvania in 1966. Thereafter, she pursued postdoctoral studies at the Weizmann Institute of Science in Israel in physical organic chemistry and at the Fox Chase Cancer Center in biochemistry. In 1978, she began her professorship at UC Berkeley, where she remains to this day.

In his letter of support of Klinman’s nomination, Amnon Kohen of the University of Iowa emphasized “her discoveries of new biological cofactors that result from auto-catalyzed post-translational modification of natural amino acids; the elucidation of quantum mechanical effects in biological catalysis, and the identification of protein motions as the next critically under-understood area in enzymology.”

JoAnne Stubbe of the Massachusetts Institute of Technology added, “Judith’s contributions have received international recognition and have established her as arguably the best chemist studying detailed enzymatic mechanisms, in the world.”

Klinman’s pioneering discoveries have positioned her both at the forefront and interface of chemistry, biochemistry and biophysics.

“One of the most admirable characteristics of Judith is her willingness to set aside old theories and embrace new theories in an effort to explain the experimental data and understand the underlying fundamental principles,” said Sharon Hammes-Schiffer from the University of Illinois at Urbana-Champaign.

A member of both the American Academy of Arts and Sciences and the National Academy of Sciences, Klinman served as the president of the ASBMB from 1998 to 1999. She has received many awards, including the Merck Award from the ASBMB in 2007 and the National Medal of Science in 2014.

Previous Cohn award recipients include Lila M. Gierasch (2014) and Jennifer A. Doudna (2013).

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Elizabeth Meier
Elizabeth Meier

Elizabeth Meier is a third-year Ph.D. student at Johns Hopkins School of Medicine, where she studies bacterial cell division in Erin Goley's lab. Originally from Portland, Ore., she completed her undergraduate studies at Scripps College, a small liberal arts college in Southern California. There, she minored in Latin American studies and majored in biology. She would love to find a career that integrates both her humanities and science backgrounds.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

ASBMB names 2025 Marion B. Sewer scholarship recipients
Society News

ASBMB names 2025 Marion B. Sewer scholarship recipients

Aug. 21, 2025

Ten undergraduates interested in biochemistry and molecular biology will each receive $2,000 toward their tuition and related educational costs.

Attie named honorary professor
Member News

Attie named honorary professor

Aug. 18, 2025

This award includes $100,000 of research funding and recognizes faculty who have made major contributions to the advancement of knowledge through their research, teaching and service activities.

Meet the 2025 SOC grant awardees
Outreach

Meet the 2025 SOC grant awardees

Aug. 15, 2025

Five science outreach and communication projects received up to $1,000 from ASBMB to promote the understanding of molecular life science.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.